treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...
. Distinguishing Characteristics of this Level N/A BEHAVIORAL HEALTH THERAPIST Job Level: F2 Duke is an Equal Opportunity... expression, gender identity, genetic information, national origin, race, religion, sex (including pregnancy and pregnancy related...
. Distinguishing Characteristics of this Level N/A Job Code: 00005028 CLINICAL SOCIAL WORKER Job Level: F2 Duke..., color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex...
departmental, hospital and/or DUHS initiatives. Distinguishing Characteristics of this Level N/A Job Level: F2 Duke..., color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex...
Job Level: F2 Duke is an Equal Opportunity Employer committed to providing employment opportunity without regard... to an individual's age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race...
. Distinguishing Characteristics of this Level N/A BEHAVIORAL HEALTH THERAPIST Job Level: F2 Duke is an Equal Opportunity... expression, gender identity, genetic information, national origin, race, religion, sex (including pregnancy and pregnancy related...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...